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The purpose of this study was to investigate the expression of carcinoembryonic antigen-related cell adhesion
molecule 5 (CEACAM5) and correlate it with OPN expression and function in squamous carcinoma of tongue.
Paraffin were sections of 80 samples with squamous carcinoma of tongue and 40 samples with normal tissue of
tongue for benign lesion having undergone surgery. Immunohistochemistry (IHC) was used to study the
distribution of CEACAM5 and OPN, and double–labeling immunohistochemistry was used to observe the
relationship between CEACAM5 and OPN expression.
CEACAM5 and OPN are found in normal tissue of tongue, but with different expression pattern. CEACAM5
expression mainly with membranous staining is restricted on the superficial epithelium. However, OPN expression
with mainly cytoplasmic staining is restricted on the deep epithelium. No colocalization of CEACAM5 and OPN have
been observed in normal tissue of tongue. In squamous carcinoma of tongue, CEACAM5 expression with
cytoplasmic staining is different from normal tongue tissue with membranous staining, and the transformation of
CEACAM5 distribution from membrane to cytoplasm is an important incident for the invasion and differentiation of
tumor. CEACAM5 and OPN are colocalized in cytoplasm, and a significant correlation was observed between the
positive colocalization and the negative colocalization in the depth of invasion and the differentiation of the tumor.
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Homeostasis in normal tissue is regulated by a balance
between proliferative activity and cell loss by apoptosis
[1,2]. Attachment to correct extracellular matrix (ECM)
is essential for survival and growth of normal adhering
cells, whereas cancer cells are able to abrogate this re-
quirement. Several growth factors and cytokines play
pivotal roles in the regulation of growth and survival of
neoplastic cells through affecting integrin-mediated ad-
hesion to ECM.
Cell adhesion molecules are important mediators of
cellular contacts and cellular polarity that also modulate* Correspondence: weifengcai2012@126.com
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reproduction in any medium, provided the orproliferation, differentiation, and invasion. Osteopontin
(OPN) is a 70-kDa secreted extracellular matrix glyco-
protein with an arginine-glycine aspartate-binding motif
capable of interaction with integrin subunits [3-5]. Both
OPN and CEACAM5 are important cell adhesion mole-
cules. OPN has been demonstrated to be expressed in a
variety of human tissues, including the kidneys, thyroid,
gastrointestinal tract, breast, and endometrium, and has
been implicated in mediation of cell-cell and cell-
extracellular matrix communication that encompass
both normal and tumorigenic developmental processes,
cell adhesion, spreading, metastasis, and invasion [6-8].
CEACAM5 is a member of the carcinoembryonic
antigen and the immunoglobulin superfamily. The
CEACAM5 gene, also known as CD66e, codes for the
protein, CEA [9]. CEACAM5 was first described in 1965Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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known to be overexpressed in a majority of carcinomas,
including those of the gastrointestinal tract, the respira-
tory and genitourinary systems, and breast cancer
[11-15]. Studies have demonstrated that OPN is coloca-
lized with the CEACAM1 and enhances invasion of
CEACAM1 expressing cells [16]. At present, no infor-
mation is available on the expression of CEACAM5 and
OPN in squamous carcinoma of tongue. Our study
would at evaluating the colocalization of OPN with
CEACAM5 and the correlation with the carcinoma of
tongue invasion and the degree of differentiation.
Materials and methods
Patients
The study included 80 patients with squamous carcin-
oma of tongue and 40 patients with normal tissue of
tongue for benign lesion having undergone primary sur-
gical resection at Qilu Hospital of Shandong University
between 2008 and 2010. The clinicopathologic informa-
tion,including sex, age, tumor stage, and tumor differen-
tiation, was obtained from the clinical records. All the
diagnoses were made by three pathologists following the
WHO classification of tumors: Pathology and Genetics
tumors of digestive system.
Immunohistochemistry(IHC)
Immunohistochemistry was performed on 4-um-thick
routinely processed paraffin sections. CEACAM5 was
detected using a mouse monoclonal anti-CEACAM5 anti-
body (abcam). Sections were dewaxed, and endogenous
peroxidase was blocked by immersing the slides in a 3%
solution of hydrogen peroxide in methanol for 10 min, fol-
lowed by antigen retrieval. The slides were immersed in
0.01 mol/L citrate buffer solution (pH 6.0) and placed in a
microwave oven for 25 min. After washing in 1 mol/L
phosphate-buffer saline (PBS, pH 7.4), the sections were
covered with normal serum in a humidity chamber for
30 min at room temperature. Excess serum was rinsed off
with 1 mol/L PBS, and the sections were incubated with
the primary antibodies in a humidity chamber for 45 min
at room temperature. Then sections were rinsed with PBS
before incubation with the biotinylated second antibody
in a humidity chamber for 40 min at 37°C. After rinsing
with PBS, the streptavidin-peroxidase complex reagent
(StrepABComplex/HRP DUET, CAKO) was added. Slides
were incubated for 45 min at room temperature, then washed
in 1 mol/L PBS, and covered with 3,3,-diaminobenzidine
tetrahydrochloride solution for 15 min under the micro-
scope. Sections were then immersed in running tap
water, counterstained with hematoxylin for 1 min, fol-
lowed by a tap water bath, immersion in a series of alco-
hol baths of increasing concentrations and xylene, and
then covered with coverslips. Negative controls wereperformed in which the primary antibody was omitted.
The slides were performed using a mouse monoclonal
anti-OPN antibody (abcam) in the same way as the slides
for OPN staining.
Double-labeling immunohistochemistry
OPN and CEACAM5 were performed by double stain-
ing against OPN (abcam) and CEACAM5 (abcam)
according to the manufacturer,s instructions (Zymed
HISTOSTAIN-DS BROAD SPECTRUM). Each antibody
labeling was performed as described above. Tween-20
PBS (0.05% TPBS, pH 7.4) was used as the buffer. Stain-
ing was performed consecutively with CEACAM5 as the
first staining. CEACAM5 and OPN labelings were per-
formed by using different chromogens (AEC AND
BCIP/NBT, respectively). Negative controls were per-
formed by displacing primary antibodies with PBS.
Evaluation of CEACAM5 and OPN staining
Histological and IHC evaluations were independently
made by three pathologists. Slides with debating evalu-
ation were re-evaluated, and a consensus was reached.
For each sample, at least 3000 carcinoma cells were eval-
uated for CEACAM5 or OPN expression. We examined
the sections at 200× magnification, and the percentage
of carcinoma cells with membranous or cytoplasmic
staining was determined.
Statistical analysis
Statistical annlysis was performed by using SPSS 10.0
software package for Windows. The chiaquare test was
used to analyze the data. Differences were considered
significant at Р<0.05.
Result
OPN, CEACAM5 expression and colocalization
Our IHC study showed that OPN and CEACAM5 ex-
pression were found in normal tongue tissue, but with
different expression pattern and location. CEACAM5
expression with membranous staining was restricted
on the superficial epithelium (mainly granular layer,
Figure 1A). However, OPN expression with mainly cyto-
plasmic staining was restricted on the deep epithelium
(mainly basal layer, Figure 1B). Fourteen out of all 40
normal tissue CEACAM5 was expressed with membran-
ous staining, six cases with a cytoplasmic staining and
five with a mixed pattern of cytoplasmic and
membranous staining. Twenty out of all 40 normal tis-
sue expressed OPN with cytoplasmic staining, six cases
expressed OPN with membranous staining, seven cases
expressed OPN with a mixed pattern of cytoplasmic and
membranous staining. The expression patterns showed a
significant different between OPN and CEACOM5 in
normal tissue (Table 1). According to dual-labeling IHC
Figure 1 In both of normal tissue and carcinoma, OPN were all expressed with mainly cytoplasmic staining (arrow) (A and B).
CEACAM5 expression was found in normal tongue tissue and carcinoma with different expression pattern and location. CEACAM5 expression
with membranous staining was restricted on the superficial epithelium(arrow) (C) in normal tissue. However, CEACAM5 expression with mainly
cytoplasmic staining was restricted on the deep epithelium (arrow) (D) in squamous carcinoma of tongue.
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expressed in the normal tissue, and no colocalization
was observed in cytoplasm (Figure 2A).
In squamous carcinoma of tongue, 59 of 80 analyzed
tumor samples have been found to express OPN withTable 1 Clinicopathological Characteristics of the Patients
Postive samples Staining pattern p values
M C M+C
CEACAM5
Normal 25 14 6 5
Carcinoma 68 6 56 6
<0.05
OPN
Normal 33 6 20 7
Carcinoma 70 6 59 5
>0.05
Normal tissue
OPN 25 14 6 5
CEACAM5 33 6 20 7
<0.01
Carcinoma
OPN 70 6 56 5
CEACAM5 68 6 56 6
>0.05
M: membranous; C: cytoblasmic; M+C: membranous and cytoblsmic.
Significant, P<0.05.cytoplasmic staining, six cases with membranous stain-
ing and five cases with a mixed pattern of cytoplasmic
and membranous staining. 56 of 80 analyzed tumor sam-
ples expressed CEACOM5 with cytoplasmic staining, six
cases with membranous staining and six cases with a
mixed pattern of cytoplasmic and membranous staining
in all of 68 analyzed positive tumor samples (Figure 1C
and D). CEACAM5 expression with cytoplasmic staining
was different from normal tongue tissue with membran-
ous staining. The expression patterns of CEACOM5
showed a significant difference between normal tissue
and the squamous carcinoma (Table 1). In addition, we
could demonstrate that 42 in all of 80 tumor samples,
CEACAM5 and OPN are being colocalized in cytoplasm
(Figure 2B) by using double-labeling immunohistochem-
istry. A significant correlation was observed between the
positive colocalization and the negative colocalization in
the depth of tumor invasion and differentiation (Table 2).
Dual-labeling IHC showed that the movement of
CEACAM5 from membrane to cytoplasm may promote
OPN expression, and more colocalization cases were
detected in squamous carcinoma of tongue. The findings
demonstrated that the transformation of CEACAM5 ex-
pression pattern and colocalization with OPN might play
a critical role in tumor metastasis and invasion.
Discussion
The human CEACAM5 protein family encompasses
several forms of proteins with different biochemical











Figure 2 OPN and CEACAM5 expression with different expression pattern and location were found in normal tongue tissue. CEACAM5
expression with membranous staining was restricted on the superficial epithelium (black arrow) (A), however, OPN expression with mainly
cytoplasmic staining was restricted on the deep epithelium (red arrow) (A). no colocalization was observation in cytoplasm (A). In squamous
carcinoma of tongue, OPN (red arrow) and CEACAM5 (black arrow) expression were found with cytoplasmic staining (B). CEACAM5 and OPN are
being colocalized in cytoplasm (green arrow) (B).
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approximately 200 kDa [17]. CEACAM5 is overex-
pressed in several tumor types of epithelial origin and is
known as an important and extensively used clinical
tumor marker for colorectal and other carcinomas [18].
Hence, CEACAM5 is an attractive target for immu-
notherapeutic purposes because of its expression profile,
its role in tumor progression, and its immunogenicity. In
benign and malignant lesions of human carcinoma oftongue, the apical membrane expression of CEACAM5
changes to a distinct uniform membrane staining in an
early stage of malignant transformation, and the incident
of the uniform membrane expression might be due to a
loss of or reduction in the interaction among the adhe-
sion molecules with its binding molecules, implicating
an important shift towards the malignant phenotype
[19]. Using immunohistochemistry, we found that nor-
mal tissue of tongue expressed CEACAM5 with apical
Table 2 Clinicopathologica Characteristics of the Patients
Variables No.of patients Colocalization p
Negative Positive
Tissue
Normal 80 40 0
Carcinoma 40 42 38
Carcinoma
Differentiation
Undifferentiated 43 16 27




T1-2 45 29 16
T3-4 35 14 21
<0.05
Significant, P<0.05.
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mainly expressed CEACAM5 with a cytoplasmic pattern.
Therefore, membranous distribution of CEACAM5
changed to cytoplasmic staining may indicate a malig-
nant transformation .
OPN is a calcium-binding phosphoprotein with mul-
tiple functions. Under physiological conditions, OPN is
produced by osteoblasts when stimulated by calcitriol,
and it functions by binding to hydroxyapatite to provide
the anchoring of osteoclast to the mineral of bone
matrix [20]. OPN binds to cells via the vitronectin re-
ceptor but also via other integrins and the hyaluronic
acid receptor CD44. Several studies have defined OPN
as an important glycoprotein with multiple functions
and have found it plays a role in basic cellular processes,
such as neovascularization and tissue remodeling, which
are essential to metastasis and invasion of the tumor
[21,22]. Furthermore, several lines of evidence have
implicated OPN in angiogenesis, and vascular endotheli-
lal growth factor may induce expression of OPN as well
as αv ß3 integrin in endothelial cells [23-25]. Overex-
pression of OPN in tongue cancers implicated a more
aggressive tumor behavior and was an important factor
for survival [26,27]. Having assessed the distribution of
OPN protein by immunohistochemistry, we found that
OPN is expressed in a large percentage of the tissue
studied. Significant cytoplasmic OPN staining was
observed in a large percentage of all tissue studied.
In the present study, we have investigated the ex-
pression pattern of OPN at all tissue studied and its
correlation with the expression of CEACAM5. As
shown by immunohistochemistry, significant cytoplas-
mic OPN staining was observed in a large percentageof all tissue studied. CEACAM5 expression with mem-
branous staining was found in normal tongue tissue.
In squamous carcinoma of tongue, CEACAM5 expres-
sion with cytoplasmic staining was different from
normal tongue tissue with membranous staining.
According to dual-labeling IHC staining of CEACOM5
and OPN, both of them were expressed in the normal
tissue, and no colocalization was observed. However,
CEACAM5 and OPN are being colocalized in squa-
mous carcinoma of tongue, and a significant correl-
ation was observed between the positive colocalization
and the negative colocalization in the depth of tumor
invasion and the differentiation. OPN and CEACAM5
were expressed in both normal and pathological
tongue tissues, and their different expression pattern
can be potentially useful as an additional diagnostic
marker in squamous carcinoma of tongue. Julianne
Briese et al. have demonstrated that OPN is coloca-
lized with the CEACAM1 in the extravillous tropho-
blast of the human placenta and enhances invasion of
CEACAM1-expressing placental cells [16]. We have
performed a systematic immumohistochemical study
on OPN and CEACAM5 protein expression in squa-
mous carcinoma of tongue. Limitations of our study
include the absence of in vitro experiment and func-
tional studies. Nevertheless, with the IHC of the corre-
lated expression pattern of OPN and CEACAM5 in
carcinoma, our data showed that OPN and CEACAM5
may act as a functional complex in these lesions. This
complex may increase invasion and inhibit differenti-
ation of the carcinoma of tongue.
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